Filed by the Registrant ☐
|
|
Filed by a Party other than the Registrant ☒
|
|
Check the appropriate box:
|
|
☒
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☐
|
Definitive Proxy Statement
|
☐
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
ASHLAND GLOBAL HOLDINGS INC.
|
|
(Name of Registrant as Specified In Its Charter)
|
|
Cruiser Capital Advisors, LLC
Keith M. Rosenbloom
Cruiser Capital Master Fund LP
Metamorphosis IV LLC
Allen A. Spizzo
William H. Joyce
Patrick E. Gottschalk
Carol S. Eicher
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
-with copies to-
|
|||||
Phillip M. Goldberg
Foley & Lardner LLP 321 North Clark Street Suite 2800
Chicago, IL 60654-5313 (312) 832-4549
|
Peter D. Fetzer
Foley & Larder LLP 777 East Wisconsin Avenue Suite 3800
Milwaukee, WI 53202-5306 (414) 297-5596
|
||||
Payment of Filing Fee (Check the appropriate box):
|
|||||
☒
|
No fee required.
|
||||
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
||||
(1)
|
Title of each class of securities to which transaction applies:
|
||||
(2)
|
Aggregate number of securities to which transaction applies:
|
||||
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
||||
(4)
|
Proposed maximum aggregate value of transaction:
|
||||
(5)
|
Total fee paid:
|
||||
☐
|
Fee paid previously with preliminary materials.
|
||||
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||||
(1)
|
Amount Previously Paid:
|
||||
(2)
|
Form, Schedule or Registration Statement No.:
|
||||
(3)
|
Filing Party:
|
||||
(4)
|
Date Filed:
|
1.
|
To vote “FOR” the election of Allen A. Spizzo, William H. Joyce, Patrick E. Gottschalk and Carol S. Eicher to the Board of Directors of the Company (the “Board”).
|
2.
|
To vote [•] a non-binding advisory resolution approving the compensation paid to Ashland Global’s named executive officers.
|
·
|
Ratification on an advisory (non-binding) basis of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal 2019.
|
|
|
1.
|
FOR the election of Allen A. Spizzo, William H. Joyce, Patrick E. Gottschalk and Carol S. Eicher.
|
2.
|
[•] the approval on an advisory (non-binding) basis of the compensation of the Company’s named executive officers.
|
3.
|
FOR the ratification on an advisory (non-binding) basis of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal 2019.
|
·
|
If your shares are registered in your own name, please sign and date the enclosed WHITE proxy card and return it today in the enclosed postage-paid envelope.
|
·
|
If your shares are held in a brokerage account or by a bank or other holder of record, you are considered the beneficial owner of the shares held in “street name,” and these proxy materials, together with a WHITE voting form, are being forwarded to you by your broker, bank or other holder of record. As a beneficial owner, you must instruct your broker, trustee or other representative how to vote. Your broker cannot vote your shares on your behalf without your instructions. Depending upon your broker, bank or other holder of record, you may be able to vote either by telephone or by the Internet. You may also vote by signing, dating and returning the enclosed voting form.
|
·
|
October 27, 2017, Cruiser Capital submitted to Ashland Global three director nominees to stand for election at the January 2018 Annual Meeting.
|
·
|
November 27, 2017, following discussions with Ashland Global, Cruiser Capital withdrew its director nominations after the Company agreed to nominate Jerome Peribere to sit on the Board.
|
·
|
November 28, 2017, Ashland Global announced that it is nominating Mr. Peribere as a Director at the 2018 Annual Meeting. Chairman and CEO William A. Wulfsohn publicly thanked Cruiser Capital for its assistance in recruiting Mr. Peribere.
|
·
|
November 29, 2017, Mr. Wulfsohn and Seth Mrozek have breakfast with Charlie J. Rose of Cruiser Capital. At that breakfast meeting Mr. Rose asked, and Mr. Wulfsohn agreed, to allow Cruiser Capital to present directly to the Board. Later that same day at a lunch meeting Mr. Wulfsohn said directly to Mr. Rosenbloom that Cruiser Capital will be allowed to address the Board at some point in the first quarter of 2018.
|
·
|
December 20, 2017, Cruiser Capital had a call with Barry Perry and Mr. Wulfsohn. On the call Cruiser Capital noted that it felt bringing Mr. Peribere on the Board would be highly accretive and that investors generally agreed. Cruiser Capital noted that there was still a large value gap between Ashland Global’s stock market value and its inherent value.
|
·
|
February 23, 2018, Cruiser Capital sent an email to Ashland Global enquiring as to when Cruiser Capital can present to the Board, as a follow-up on management’s commitment to allow Cruiser Capital to present stockholder concerns directly to the Board.
|
·
|
March 2, 2018, Ashland Global sent an email to Cruiser Capital withdrawing its commitment to allowing Cruiser Capital to present stockholder concerns directly to the Board.
|
·
|
May 2, 2018, Cruiser Capital requested to speak with Ashland Global management following the fiscal second quarter earnings. Ashland Global did not respond to the request.
|
·
|
July 16, 2018, Cruiser Capital sent the Board a letter expressing concerns about Ashland Global’s history as a financial sponsor and lack of operational execution. Cruiser Capital recommended that they appoint two new directors to the Board, with Dr. Joyce being retained by the Company as an advisor. In the letter, Cruiser Capital recommended that Mr. Spizzo be considered as a Director. Cruiser Capital noted specifically that the “opportunities to grow revenues and to reduce expenses (without necessarily reducing headcount) are ripe.” Cruiser Capital also noted that it had other concerns and ideas to discuss, including thoughts on improving growth and margins, that it would like to share with the Board.
|
|
|
·
|
July 23, 2018, Cruiser Capital filed a Schedule 13D and disclosed, among other things, its working relationship with Dr. Joyce and Mr. Spizzo, who have invested $35 million in Ashland Global. (Dr. Joyce owns shares through trusts that are advised by Cruiser Capital Advisers, LLC (Cruiser Capital Advisers is the beneficial owner pursuant to Rule 13d-3 of the Securities Exchange Act of 1934), and Mr. Spizzo owns shares in his own name.)
|
·
|
July 24, 2018, Cruiser Capital had a conference call with Ashland Global’s management. During that call Mr. Rosenbloom stated that he believed that Mr. Wulfsohn personally, and the Company as a whole, would benefit from a discussion with Dr. Joyce. It was stated that Dr. Joyce had given a lot of thought on how to improve Ashland Global’s margins in a way that impressed Cruiser Capital as a stockholder, and that Cruiser Capital believed would impress management as well. Cruiser Capital offered to provide the contact information of Dr. Joyce and the other people mentioned in the July 16, 2018 letter to Ashland Global, and Ashland Global’s management declined to get their contact information.
|
·
|
On the July 24, 2018 call, Ashland stated that Cruiser's July 16th letter spoke for itself and needed no further clarity. Cruiser Capital noted that we have a long and in depth presentation that we would like to share with the Chairman and the Board which was our understanding from November. Cruiser stated that our goal is not to agitate, but to help improve the business.
|
·
|
August 1, 2018, Cruiser Capital asked Ashland Global if Dr. Joyce and Mr. Spizzo could join a previously scheduled call to discuss Ashland’s earnings release and business prospects.
|
·
|
August 2, 2018, Ashland explicitly requested that Dr. Joyce and Mr. Spizzo not join the earnings review call.
|
·
|
August 2, 2018, Cruiser Capital had a call with management to review Ashland Global’s fiscal third quarter results. Cruiser Capital stated that Mr. Spizzo lives near Ashland Global corporate headquarters in Delaware and as such it would be very convenient for a meeting between the Company and Mr. Spizzo to occur in person.
|
·
|
August 3, 2018, in response to Cruiser Capital’s July 16th letter, Mr. Perry, Lead Independent Director of the Board, sends Cruiser Capital a letter declining to speak directly with Cruiser, directing Cruiser to communicate directly with management.
|
|
|
·
|
September 11, 2018, Cruiser Capital met with CFO Kevin Willis at an investor conference. Cruiser Capital again expressed that it believes it would be beneficial for Ashland Global to speak with both Dr. Joyce and Mr. Spizzo, without Cruiser present, to discuss opportunities to improve Ashland Global. It was expressed that both Dr. Joyce and Mr. Spizzo have no desire to become CEO or serve in a corporate executive role at Ashland Global. At the meeting, Cruiser Capital stated clearly that Mr. Spizzo lives near the Company’s Delaware headquarters and would be happy to meet with Ashland's management there.
|
·
|
October 15, 2018, Cruiser Capital had a call with Ashland Global’s management. It was reiterated that Dr. Joyce and Mr. Spizzo were stockholders who had no desire to become corporate executives at Ashland Global and only want to share information because they believe they can add value for all stockholders.
|
·
|
On October 15, 2018, Cruiser Capital asked Ashland Global why the Company had not met with Dr. Joyce or Mr. Spizzo. Management stated that for a nominee to be considered their nomination must be formally submitted. Then the Company will follow its “Director review process” in considering the particular nominees. As a result, Cruiser Capital informed Ashland Global that Cruiser would submit for nomination four nominees to the Board, including Dr. Joyce and Mr. Spizzo which would be required to be made public.
|
·
|
October 23, 2018, we submitted to Ashland Global our notice of intent to nominate Allen A. Spizzo, William H. Joyce, Patrick E. Gottschalk and Carol S. Eicher to the Board at the Company’s 2019 Annual Meeting of Stockholders. We filed the nomination letter with the SEC in an amended Schedule 13D on October 25, 2018.
|
·
|
October 25, 2018, Ashland Global issued a press release confirming the receipt of our notice of our Director nominations.
|
·
|
November 2018, a recruiter hired by Ashland Global calls each nominee and engages in a discussion about their background. The recruiter does not solicit the nominees’ insights into improving Ashland Global. Neither the Board nor the Company’s management talks directly with any of our nominees.
|
·
|
November 20, 2018, Cruiser Capital sent a letter to the Chairman and CEO, Mr. Wulfsohn, Mr. Perry, Lead Independent Director, and Brendan Cummins, Head of the Governance and Nominating Committee, expressing concerns regarding lack of stockholder engagement, a concern regarding premature M&A activity at a sub-optimal price, and concerns regarding persistent operational underperformance. In that letter Cruiser Capital asked why the Company’s management had still not met with Dr. Joyce or Mr. Spizzo.
|
·
|
December 7, 2018, we filed our Preliminary Proxy Statement.
|
|
|
Allen A. Spizzo: |
Since 2008, Mr. Spizzo, age 61, has been a business and management consultant focused on the chemicals, materials, biotechnology and pharmaceutical industries. He also serves as an investment adviser and asset management trustee. Mr. Spizzo served as Vice President and Chief Financial Officer of Hercules Incorporated, a former S&P 500 company, from March 2004 until the company was sold to Ashland Inc. in November 2008. He served as Vice President, Corporate Affairs, Strategic Planning and Corporate Development of Hercules from July 2002 to March 2004. He served as Vice President, Investor Relations and Strategic Planning of Hercules from 2000 to July 2002. Prior to that, he served in other capacities with Hercules beginning in 1979. Mr. Spizzo received a BS in Chemical Engineering from North Carolina State University and an MBA from University of Akron. He is currently a Director of Ferro Corporation, a global specialty materials business, where he is a member of the Audit and Compensation Committee. He also serves on the board of directors of Global Specimen Solutions, Inc., a privately held informatics company serving the pharmaceutical and biotech industries headquartered in Raleigh, North Carolina. Mr. Spizzo recently served on the board of directors of OM Group, Incorporated, a global specialty chemicals and materials company, until its sale in 2015 and A. Schulman until its sale to LyondellBasell Industries. The Stockholder Nominees for New Directors of Ashland believe that Mr. Spizzo’s extensive management experience in positions in key corporate functions (including, finance, strategic planning, corporate development and investor relations), as well as his experience on public company boards, qualifies him to serve on the Company’s Board.
|
William H. Joyce: |
Dr. Joyce, age 82, has been the Chairman and Chief Executive Officer of Advanced Fusion Systems LLC, a developer and manufacturer of power electronics, since 2008. He is the retired, former Chief Executive Officer and Chairman of Nalco Holding Company, positions he held from November 2003 until his retirement in December 2007. Prior to joining Nalco, Dr. Joyce served as Chief Executive Officer and Chairman at Hercules Incorporated and prior to that at Union Carbide. Dr. Joyce holds a B.S. degree in Chemical Engineering from Penn State University, and MBA and Ph.D. degrees from New York
|
Patrick E. Gottschalk: |
Mr. Gottschalk, age 55, is the former Chairman and CEO of Union Carbide from 2007 until 2012. Most recently Mr. Gottschalk served as President of Coatings, Monomers and Additives, a multi-billion dollar business within The Dow Chemical Co., which is a chemicals manufacturer, and served in this capacity from 2012 until 2016. Mr. Gottschalk currently serves as a director of Superior Plus Corporation (TXS:SPB). The Stockholder Nominees for New Directors of Ashland believe that Mr. Gottschalk’s extensive management experience, and his skills in business leadership and strategy, qualifies him to serve on the Company’s Board.
|
Carol S. Eicher: |
Since 2008, Ms. Eicher, age 60, has served as a director for Tennant Company, a cleaning products and solutions company. Ms. Eicher currently serves as a member of the governance and compensation committees, and formerly served on the audit committee, for Tennant Company. Ms. Eicher is currently a Director at Aurora Plastics where she is a member of the Audit Committee. Ms. Eicher previously served as President and Chief Executive Officer, for Innocor Inc., a designer and manufacturer of home furnishings company. In addition, Ms. Eicher has served as a director and treasurer for Fairmount Park Conservancy, a nonprofit corporation since 2005 and was a Director at A. Schulman from 2017 to 2018 until its sale to LyndellBasell Industries. Ms. Eicher’s past business experience includes serving as Business President of Coating Materials and Building and Construction for The Dow Chemical Company, a manufacturer and seller of chemicals, plastic materials and other specialized products. The Stockholder Nominees for New Directors of Ashland believe that the attributes, skills and qualifications Ms. Eicher has developed through her global manufacturing, operations, and merger and acquisition experience allow her to provide business and leadership expertise to the Board
|
·
|
Dr. Joyce: Hexion Inc. (the supervision of the management of Hexion Inc.’s affairs and business operations is entrusted to the Board of Managers of Hexion Holdings LLC, Columbus OH, and Dr. Joyce is a director of Hexion Holdings LLC)
|
·
|
Mr. Spizzo: Ferro Corp. (NYSE: FOE); A. Schulman, Inc. (NASDAQ: SHLM); and OM Group (NYSE: OMG)
|
·
|
Mr. Gottschalk: Superior Plus Corporation (TSX: SPB
|
|
|
·
|
Ms. Eicher: Tennant Co. (NYSE: TNC); and A. Schulman, Inc. (NASDAQ: SHLM)
|
·
|
[•]
|
·
|
[•]
|
·
|
[•]
|
·
|
[•]
|
·
|
If your shares are registered in your own name, please sign and date the enclosed WHITE proxy card and return it today in the enclosed postage-paid envelope.
|
·
|
If your shares are held in a brokerage account or by a bank or other holder of record, you are considered the beneficial owner of the shares held in “street name,” and these proxy materials, together with a WHITE voting form, are being forwarded to you by your broker, bank or other holder of record. As a beneficial owner, you must instruct your broker, trustee or other representative how to vote. Your broker cannot vote your shares on your behalf without your instructions. Depending upon your broker, bank or other holder of record, you may be able to vote either by telephone or by the Internet. You may also vote by signing, dating and returning the enclosed voting form.
|
1.
|
FOR the election of Allen A. Spizzo, William H. Joyce, Patrick E. Gottschalk and Carol S. Eicher to the Board, and “FOR” the persons who have been nominated by Ashland Global to serve as Directors, other than Ashland Global nominees [•], [•], [•] and [•].
|
2.
|
[•] the approval on an advisory (non-binding) basis the compensation of the Company’s named executive officers.
|
3.
|
FOR the ratification on an advisory (non-binding) basis the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending September 30, 2019.
|
Name
|
Principal Occupation or Employment
|
Name, Business and Address Employer
|
Cruiser Capital Advisors, LLC
|
The principal business of Cruiser Capital Advisors is to serve as an investment manager or adviser to various pooled investment vehicles, including Cruiser Capital Master Fund LP and Metamorphosis IV LLC, and separately managed accounts.
|
501 Madison Avenue, Floor 12A, New York, NY 10022.
|
Keith M. Rosenbloom, age 50
|
The principal occupation of Mr. Rosenbloom is investment management through his ownership and control over the affairs of Cruiser Capital Advisors.
|
Cruiser Capital Advisors, LLC, an investment adviser located at 501 Madison Avenue, Floor 12A, New York, NY 10022.
|
Cruiser Capital Master Fund LP
|
Serves as a pooled investment vehicle.
|
501 Madison Avenue, Floor 12A, New York, NY 10022.
|
Metamorphosis IV LLC
|
Serves as a pooled investment vehicle.
|
501 Madison Avenue, Floor 12A, New York, NY 10022.
|
Allen A. Spizzo, age 61
|
Mr. Spizzo is a business and management consultant focused on the chemicals, materials, biotechnology and pharmaceutical industries.
|
Mr. Spizzo conducts his business from 7013 Marseilles Court Summerfield, NC 27358.
|
William H. Joyce, age 82
|
Dr. Joyce has been the Chairman and Chief Executive Officer of Advanced Fusion Systems LLC, a developer and manufacturer of power electronics, since 2008.
|
Advanced Fusion Systems LLC is a developer and manufacturer of power electronics located at 11 Edmond Road, Newtown, CT 06470.
|
Patrick E. Gottschalk, age 55
|
Mr. Gottschalk was previously the President of Coatings, Monomers and Additives, a business within the Dow Chemical Co.
|
200 West Washington Square #3202 Philadelphia, PA 19106
|
Carol S. Eicher, age 60
|
Ms. Eicher serves as a director for Tennant Company, a cleaning products and solutions company.
|
c/o Cruiser Capital Advisors, LLC, 501 Madison Avenue, Floor 12A, New York, NY 10022
|
Name
|
Business Address
|
Cruiser Capital Advisors, LLC
|
501 Madison Avenue, Floor 12A
New York, NY 10022 |
Cruiser Capital Master Fund LP
|
501 Madison Avenue, Floor 12A
New York, NY 10022 |
Metamorphosis IV LLC
|
501 Madison Avenue, Floor 12A
New York, NY 10022 |
Metamorphosis Master Fund LP
|
501 Madison Avenue, Floor 12A
New York, NY 10022 |
Cruiser Capital Metamorphosis Advisors, LLC
|
501 Madison Avenue, Floor 12A
New York, NY 10022 |
Cruiser Capital, LLC
|
501 Madison Avenue, Floor 12A
New York, NY 10022 |
Cruiser Capital, Ltd.
|
501 Madison Avenue, Floor 12A
New York, NY 10022 |
Name and Address
|
Shares Held Beneficially
|
Percent of Class Beneficially Owned
|
Shares Held of Record
|
Shares Held By
Non-Participant Associates |
Cruiser Capital Advisors, LLC
501 Madison Avenue, Floor 12A
New York, NY 10022
|
1,535,324 (3)
|
2.5%
|
0
|
0
|
Keith M. Rosenbloom
501 Madison Avenue, Floor 12A
New York, NY 10022
|
1,535,324 (4)
|
2.5%
|
0
|
0
|
Cruiser Capital Master Fund LP
501 Madison Avenue, Floor 12A
New York, NY 10022
|
0 (1)
|
0%
|
4,790 (1)
|
0
|
Metamorphosis IV LLC
501 Madison Avenue, Floor 12A
New York, NY 10022
|
0 (2)
|
0%
|
0 (2)
|
0
|
Allen A. Spizzo
501 Madison Avenue, Floor 12A
New York, NY 10022
|
4,330
|
Less than 1%
|
0
|
0
|
William H. Joyce
501 Madison Avenue, Floor 12A
New York, NY 10022
|
0 (5)
|
0%
|
0
|
0
|
Patrick E. Gottschalk
501 Madison Avenue, Floor 12A
New York, NY 10022
|
1,000
|
Less than 1%
|
0
|
0
|
Carol S. Eicher
501 Madison Avenue, Floor 12A
New York, NY 10022
|
0 (6)
|
0%
|
0 (6)
|
0
|
(1)
|
Cruiser Capital Master Fund LP is the record holder of these shares of common stock. All of the other shares of common stock are held in street name, and pursuant to Rule 13d-3 of the Exchange Act, Cruiser Capital Master Fund LP does not hold these shares beneficially.
|
(2)
|
Metamorphosis IV LLC is not the record holder of any shares of common stock. All of the shares of common stock held by Metamorphosis IV LLC are held in street name, and pursuant to Rule 13d-3 of the Exchange Act, Metamorphosis IV LLC does not hold these shares beneficially.
|
(3)
|
Cruiser Capital Advisors has sole voting and dispositive power over these shares, which it manages for Cruiser Capital Master Fund LP, Metamorphosis IV LLC, and separately managed accounts (collectively, the “Cruiser Clients”)
|
(4)
|
Because Mr. Rosenbloom is the managing member of Cruiser Capital Advisors, he is deemed to share voting power and dispositive power over the shares of common stock managed for the Cruiser Clients.
|
(5)
|
There are 472,425 shares of common stock in the account of Dr. Joyce, which was entered into by trusts in which Dr. Joyce is a trustee. Mr. Spizzo also serves as a trustee for these trusts. Pursuant to Rule 13d-3 of the Exchange Act, Dr. Joyce and Mr. Spizzo do not hold these shares beneficially
|
|
|
(6)
|
Ms. Eicher is an investor in Metamorphosis IV LLC. If Ms. Eicher is elected as a director of the Company, then Ms. Eicher will be redeemed out of Metamorphosis IV LLC.
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
10/25/2017
|
1,001*
|
10/27/2017
|
2,846*
|
10/27/2017
|
889
|
10/27/2017
|
627
|
10/27/2017
|
62
|
10/27/2017
|
5,221
|
10/31/2017
|
1,072*
|
10/31/2017
|
549
|
10/31/2017
|
293
|
10/31/2017
|
53
|
11/3/2017
|
552*
|
11/3/2017
|
274
|
11/3/2017
|
146
|
11/3/2017
|
28
|
11/6/2017
|
17,200*
|
11/6/2017
|
7,000
|
11/6/2017
|
4,750
|
11/6/2017
|
1,500
|
11/6/2017
|
10,250
|
11/16/2017
|
29,000
|
11/30/2017
|
(2,881)*
|
11/30/2017
|
(762)
|
11/30/2017
|
(1,429)
|
11/30/2017
|
(150)
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
1/17/2018
|
2,000*
|
1/26/2018
|
(2,195)*
|
1/26/2018
|
(527)
|
1/26/2018
|
(757)
|
1/26/2018
|
(126)
|
1/26/2018
|
(2,421)
|
1/29/2018
|
364*
|
1/29/2018
|
126
|
1/29/2018
|
88
|
1/29/2018
|
20
|
1/29/2018
|
402
|
2/2/2018
|
3,101*
|
2/2/2018
|
1,242
|
2/2/2018
|
657
|
3/1/2018
|
20,000**
|
3/2/2018
|
611*
|
3/2/2018
|
239
|
3/2/2018
|
125
|
3/2/2018
|
25
|
3/8/2018
|
2,000
|
3/13/2018
|
7,600**
|
3/14/2018
|
10,000**
|
3/15/2018
|
100**
|
3/20/2018
|
10,000**
|
3/21/2018
|
20,000**
|
3/22/2018
|
766*
|
3/22/2018
|
60,000**
|
3/22/2018
|
298
|
3/22/2018
|
156
|
3/22/2018
|
31
|
3/22/2018
|
749
|
3/22/2018
|
1,000
|
3/22/2018
|
1,000
|
3/22/2018
|
1,000
|
3/22/2018
|
82,850
|
3/23/2018
|
50,000**
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
3/26/2018
|
611*
|
3/26/2018
|
239
|
3/26/2018
|
125
|
3/26/2018
|
25
|
3/26/2018
|
12,500**
|
3/27/2018
|
46,700**
|
3/28/2018
|
31,200**
|
3/29/2018
|
611*
|
3/29/2018
|
239
|
3/29/2018
|
125
|
3/29/2018
|
25
|
4/2/2018
|
980*
|
4/2/2018
|
346
|
4/2/2018
|
230
|
4/2/2018
|
49
|
4/2/2018
|
919
|
4/2/2018
|
50,000**
|
4/3/2018
|
388*
|
4/3/2018
|
137
|
4/3/2018
|
91
|
4/3/2018
|
20
|
4/3/2018
|
364
|
4/3/2018
|
14,500**
|
4/4/2018
|
25,000**
|
4/5/2018
|
388*
|
4/5/2018
|
137
|
4/5/2018
|
91
|
4/5/2018
|
20
|
4/5/2018
|
364
|
4/6/2018
|
31,500**
|
4/9/2018
|
212*
|
4/9/2018
|
82
|
4/9/2018
|
43
|
4/9/2018
|
8
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
4/11/2018
|
385*
|
4/11/2018
|
150
|
4/11/2018
|
80
|
4/11/2018
|
25
|
4/11/2018
|
360
|
4/12/2018
|
389*
|
4/12/2018
|
138
|
4/12/2018
|
91
|
4/12/2018
|
19
|
4/12/2018
|
363
|
4/13/2018
|
385*
|
4/13/2018
|
150
|
4/13/2018
|
79
|
4/13/2018
|
15
|
4/13/2018
|
371
|
4/17/2018
|
457*
|
4/17/2018
|
178
|
4/17/2018
|
93
|
4/17/2018
|
18
|
4/19/2018
|
4,742***
|
4/20/2018
|
10,000***
|
4/20/2018
|
20,000**
|
4/23/2018
|
2,000*
|
4/23/2018
|
1,000
|
4/23/2018
|
1,000
|
4/23/2018
|
21,000***
|
4/24/2018
|
10,000***
|
4/24/2018
|
25,670**
|
4/25/2018
|
3,500
|
4/25/2018
|
3,500***
|
4/26/2018
|
500*
|
4/26/2018
|
1,000
|
4/26/2018
|
3,500***
|
4/27/2018
|
15,000***
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
4/30/2018
|
2,500*
|
4/30/2018
|
1,000
|
4/30/2018
|
500
|
4/30/2018
|
3,000
|
4/30/2018
|
3,000***
|
5/1/2018
|
1,911***
|
5/1/2018
|
1,500
|
5/9/2018
|
10,200
|
5/10/2018
|
4,450
|
5/14/2018
|
338
|
5/14/2018
|
5,912
|
5/14/2018
|
5,669
|
5/14/2018
|
581
|
5/16/2018
|
24,507
|
5/17/2018
|
25,493
|
5/18/2018
|
2,200*
|
5/18/2018
|
1,700
|
5/18/2018
|
1,100
|
5/18/2018
|
600
|
5/18/2018
|
5,400***
|
5/22/2018
|
7,500
|
5/25/2018
|
250*
|
5/25/2018
|
1,000
|
5/25/2018
|
1,000
|
5/25/2018
|
250
|
5/25/2018
|
2,500***
|
5/30/2018
|
700
|
5/31/2018
|
1,000*
|
5/31/2018
|
1,000
|
5/31/2018
|
1,000***
|
6/4/2018
|
8,000
|
6/5/2018
|
2,643***
|
6/5/2018
|
2,000
|
6/6/2018
|
5,000
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
6/13/2018
|
1,000*
|
6/13/2018
|
500
|
6/13/2018
|
500
|
6/13/2018
|
1,500
|
6/13/2018
|
6,500***
|
6/15/2018
|
500*
|
6/15/2018
|
1,500***
|
6/18/2018
|
2,900
|
6/18/2018
|
11,600***
|
6/19/2018
|
5,000***
|
6/20/2018
|
600*
|
6/21/2018
|
1,920*
|
6/21/2018
|
750
|
6/21/2018
|
522
|
6/21/2018
|
110
|
6/21/2018
|
2,256
|
6/21/2018
|
4,442***
|
6/22/2018
|
25,000
|
6/25/2018
|
3,799*
|
6/25/2018
|
876
|
6/25/2018
|
1,259
|
6/25/2018
|
187
|
6/25/2018
|
5,923
|
6/25/2018
|
2,000
|
6/25/2018
|
25,000
|
6/25/2018
|
15,456***
|
6/26/2018
|
2,003*
|
6/26/2018
|
2,000
|
6/26/2018
|
1,500
|
6/26/2018
|
300
|
6/26/2018
|
2,250
|
6/26/2018
|
2,250***
|
6/26/2018
|
1,800
|
6/26/2018
|
770
|
6/26/2018
|
12,980
|
6/26/2018
|
12,458
|
6/26/2018
|
1,292
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
6/27/2018
|
2,000*
|
6/27/2018
|
81
|
6/27/2018
|
1,419
|
6/27/2018
|
1,360
|
6/27/2018
|
140
|
6/27/2018
|
11,667
|
6/27/2018
|
1,666
|
6/27/2018
|
11,667
|
6/28/2018
|
682*
|
6/28/2018
|
264
|
6/28/2018
|
138
|
6/28/2018
|
650
|
6/28/2018
|
2,502
|
6/28/2018
|
358
|
6/28/2018
|
2,502
|
7/2/2018
|
7,339*
|
7/2/2018
|
7,047
|
7/2/2018
|
1,006
|
7/2/2018
|
7,047
|
7/3/2018
|
437*
|
7/3/2018
|
5,000***
|
7/5/2018
|
100*
|
7/5/2018
|
1,300***
|
7/9/2018
|
100*
|
7/9/2018
|
9,900***
|
7/10/2018
|
35,000***
|
7/10/2018
|
2,333
|
7/10/2018
|
334
|
7/10/2018
|
2,333
|
7/11/2018
|
44,919***
|
7/11/2018
|
4,200
|
7/11/2018
|
600
|
7/11/2018
|
4,200
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
7/12/2018
|
1,000*
|
7/12/2018
|
24,000***
|
7/12/2018
|
5,000
|
7/12/2018
|
4,667
|
7/12/2018
|
666
|
7/12/2018
|
4,667
|
7/18/2018
|
3,000*
|
7/18/2018
|
2,220
|
7/18/2018
|
2,500
|
7/20/2018
|
10,275*
|
7/20/2018
|
2,896
|
7/20/2018
|
4,560
|
7/20/2018
|
400
|
7/20/2018
|
1,869
|
7/20/2018
|
15,000***
|
8/17/2018
|
3,000*
|
8/17/2018
|
107,200***
|
8/17/2018
|
25,100
|
8/17/2018
|
200
|
8/17/2018
|
4,000
|
8/17/2018
|
3,900
|
8/17/2018
|
400
|
8/31/2018
|
5,138***
|
9/28/2018
|
1,000***
|
10/8/2018
|
1,000***
|
10/9/2018
|
1,000***
|
10/11/2018
|
623*
|
10/11/2018
|
121
|
10/11/2018
|
232
|
10/11/2018
|
24
|
10/12/2018
|
3,100
|
Trade Date
|
Number of Shares Purchased or (Sold)
|
10/15/2018
|
1,000*
|
10/15/2018
|
3,000
|
10/16/2018
|
401*
|
10/16/2018
|
250
|
10/16/2018
|
100
|
10/19/2018
|
5,000***
|
10/19/2018
|
1,500
|
11/16/2018
|
14,500
|
11/21/2018
|
1,500
|
12/6/2018 | 10,000 |
Trade Date
|
Number of Shares Purchased or (Sold)
|
03/02/2018
|
1,000
|
04/02/2018
|
2,000
|
04/24/2018
|
2,000
|
04/30/2018
|
330
|
06/04/2018
|
(1,000)
|
1.
|
ELECTION OF DIRECTORS- To elect Allen A. Spizzo, William H. Joyce, Patrick E. Gottschalk and Carol S. Eicher:
|
2.
|
APPROVAL OF A NON-BINDING ADVISORY RESOLUTION APPROVING THE COMPENSATION PAID TO ASHLAND’S NAMED EXECUTIVE OFFICERS
|
3.
|
RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG, LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING SEPTEMBER 30, 2019.
|
4.
|
APPROVAL OF ANY PROPOSAL BY THE COMPANY TO ADJOURN THE ANNUAL MEETING TO ALLOW THE COMPANY TO SOLICIT ADDITIONAL VOTES.
|